GENERAL (Details)	1 Months Ended	3 Months Ended		6 Months Ended
	Jul. 31, 2016 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)	Jun. 30, 2016 USD ($) product	Jun. 30, 2015 USD ($)
Organizational disclosures
Operating losses		$ (7,067,000)	$ (6,825,000)	$ (13,302,000)	$ (12,361,000)
Negative cash flows from operating activities				$ 13,850,000	11,458,000
Issuance of equity
Net proceeds from issuance of equity					$ 36,159,000
Private Placement | Ordinary shares and warrants to purchase ordinary shares | Subsequent events.
Issuance of equity
Net proceeds from issuance of equity	$ 19,800,000
Products for Treatment Of Post-Surgical And Acute Pain In Home Setting
Organizational disclosures
Number of products in development | product				2